BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 30894861)

  • 1. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.
    Mollica Poeta V; Massara M; Capucetti A; Bonecchi R
    Front Immunol; 2019; 10():379. PubMed ID: 30894861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
    Susek KH; Karvouni M; Alici E; Lundqvist A
    Front Immunol; 2018; 9():2159. PubMed ID: 30319622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor expression on dendritic cells is normal in HIV-infected patients with a stable response to art, but chemokine levels remain elevated.
    Lee S; Fernandez S; French M; Price P
    J Med Virol; 2011 Jul; 83(7):1128-33. PubMed ID: 21567418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.
    Kieseier BC; Tani M; Mahad D; Oka N; Ho T; Woodroofe N; Griffin JW; Toyka KV; Ransohoff RM; Hartung HP
    Brain; 2002 Apr; 125(Pt 4):823-34. PubMed ID: 11912115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
    Korbecki J; Grochans S; Gutowska I; Barczak K; Baranowska-Bosiacka I
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR9 in cancer: oncogenic role and therapeutic targeting.
    Tu Z; Xiao R; Xiong J; Tembo KM; Deng X; Xiong M; Liu P; Wang M; Zhang Q
    J Hematol Oncol; 2016 Feb; 9():10. PubMed ID: 26879872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.
    Alenazi Y; Singh K; Davies G; Eaton JRO; Elders P; Kawamura A; Bhattacharya S
    Sci Rep; 2018 Apr; 8(1):6333. PubMed ID: 29679010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and role of CXC chemokines in colorectal cancer.
    Verbeke H; Struyf S; Laureys G; Van Damme J
    Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
    Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
    J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptors.
    Horuk R
    Cytokine Growth Factor Rev; 2001 Dec; 12(4):313-35. PubMed ID: 11544102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
    Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine network: a target in cancer biology?
    Slettenaar VI; Wilson JL
    Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Chemokine Receptors in Cardiovascular Disease.
    Gencer S; van der Vorst EPC; Aslani M; Weber C; Döring Y; Duchene J
    Thromb Haemost; 2019 Apr; 119(4):534-541. PubMed ID: 30716778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of CXC chemokines and their receptors in cancer.
    Vinader V; Afarinkia K
    Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of peripheral CXC and CC chemokine receptor expression on CD4
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():211-220. PubMed ID: 28986277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the immunoangiostatic CXC chemokine network.
    Balestrieri ML; Balestrieri A; Mancini FP; Napoli C
    Cardiovasc Res; 2008 May; 78(2):250-6. PubMed ID: 18252760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.